Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zosyn Continuous vs Intermittent Infusion in Complicated Intra-abdominal Infection
NCT00044928Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jul 2002
- Primary completion
- Feb 2004
- Modality
- Irreversible Covalent Inhibitors
01
Overview
A Phase 4 trial of piperacillin + tazobactam in Intra-abdominal infection (IAI), sponsored by Pfizer. Started Jul 2002; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT00044928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044928.